United Therapeutics Corp. (UTHR)

104.42
0.31 0.30
NASDAQ : Health Technology
Prev Close 104.73
Open 104.82
Day Low/High 104.37 / 107.24
52 Wk Low/High 100.57 / 152.55
Volume 72.47K
Avg Volume 427.10K
Exchange NASDAQ
Shares Outstanding 43.54M
Market Cap 4.53B
EPS 9.50
P/E Ratio 9.61
Div & Yield N.A. (N.A)

Latest News

5 Bearish Bets: Why Pepsi, Cray and 3 Other Stocks Look Good Short

5 Bearish Bets: Why Pepsi, Cray and 3 Other Stocks Look Good Short

Pepsi looks challenged and Cray's chart is 'cray cray.'

Pepsi Is Challenged, Cray’s Chart Is Cray Cray and 3 Other Stocks That Look Good Short

PEP, CULP, IT, CRAY and UTHR were all recently were downgraded by TheStreet's Quant Ratings service.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AOI, ATSG, CKH, CRM, DDS, EQBK, FSTR, GNK, NEWM, OAS, RDC, RRC, TCMD, UHS, WTW Downgrades: AHGP, AMED, AXE, CTRE, CULP, DOC, EMKR, GLW, HABT, IT, KBR, RP, SGEN, SPOK, SWM, TACO, UGP, UTHR Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against United Therapeutics Corporation - UTHR

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against United Therapeutics Corporation - UTHR

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of United Therapeutics Corporation (NASDAQ: UTHR) resulting from allegations that United...

Faruqi & Faruqi, LLP Is Investigating United Therapeutics Corporation (UTHR) On Behalf Of Its Shareholders

Faruqi & Faruqi, LLP Is Investigating United Therapeutics Corporation (UTHR) On Behalf Of Its Shareholders

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential wrongdoing at United Therapeutics Corporation ("United Therapeutics" or the "Company") (NASDAQ:UTHR).

Short Interest Falls 20% For UTHR

Short Interest Falls 20% For UTHR

The most recent short interest data has been released for the 01/31/2018 settlement date, which shows a 1,169,886 share decrease in total short interest for United Therapeutics Corp , to 4,652,309, a decrease of 20.09% since 01/12/2018. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Axovant Shares Crater as CEO and President Both Resign

Axovant Shares Crater as CEO and President Both Resign

Chief executive David Hung resigned from the Basel, Switzerland, biotech after just 10 months on the job.

Best Biotech Stock Trades and Mergers to Watch in 2018

Best Biotech Stock Trades and Mergers to Watch in 2018

Here's a look at biotech stock trades, takeout targets and pot sellers that will dominate 2018.

United Therapeutics Gets a Quantitative Upgrade

United Therapeutics Gets a Quantitative Upgrade

Shares look to break out from long basing pattern.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CHUY, KANG, NYCB, UTHR, WSTL Downgrades: DEL, LAKE Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

An Ocean Shipper, a Biotech Concern and Other Stocks That Look Good Short

UTHR, ENZ, HCI, SBLK and EVI all recently were downgraded by TheStreet's Quant Ratings.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CAMP, HAL, HWBK Downgrades: UTHR Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Biotech Movers: Buzz on Potential Suitors Sends United Therapeutics Stock Soaring

Biotech Movers: Buzz on Potential Suitors Sends United Therapeutics Stock Soaring

GlaxoSmithKline could be among the suitors for United Therapeutics, the Evening Standard reported.

UNITED THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In United Therapeutics Corporation To Contact The Firm

UNITED THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In United Therapeutics Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at United Therapeutics Corporation ("United Therapeutics" or the "Company") (NasdaqGS:UTHR).

UTHR SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of United Therapeutics Corporation

UTHR SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of United Therapeutics Corporation

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether United Therapeutics Corporation ("United Therapeutics") (NASDAQ:UTHR) violated federal securities laws.

SHAREHOLDER ALERT: Goldberg Law PC Announces An Investigation Of United Therapeutics Corporation

SHAREHOLDER ALERT: Goldberg Law PC Announces An Investigation Of United Therapeutics Corporation

Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of United Therapeutics Corporation ("United Therapeutics" or the "Company") (Nasdaq:...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of United Therapeutics Corporation -- UTHR

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of United Therapeutics Corporation -- UTHR

Levi & Korsinsky announces it has commenced an investigation of United Therapeutics Corporation ("United Therapeutics" or the "Company") (NASDAQ: UTHR) concerning possible violations of federal securities laws.

UNITED THERAPEUTICS CORPORATION (UTHR) INVESTOR ALERT: Legal Investigation For Potential Securities Law Violations

UNITED THERAPEUTICS CORPORATION (UTHR) INVESTOR ALERT: Legal Investigation For Potential Securities Law Violations

Girard Gibbs LLP is investigating potential claims on behalf of investors of United Therapeutics Corporation (NASDAQ:UTHR) regarding possible securities law violations.

TheStreet Quant Rating: C (Hold)